Park Avenue Securities LLC Purchases 43,417 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Park Avenue Securities LLC boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1,215.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,989 shares of the exchange traded fund’s stock after purchasing an additional 43,417 shares during the quarter. Park Avenue Securities LLC owned approximately 0.06% of SPDR S&P Biotech ETF worth $4,642,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. M&R Capital Management Inc. boosted its position in shares of SPDR S&P Biotech ETF by 25.1% in the 3rd quarter. M&R Capital Management Inc. now owns 1,501 shares of the exchange traded fund’s stock worth $148,000 after purchasing an additional 301 shares in the last quarter. Newbridge Financial Services Group Inc. boosted its holdings in SPDR S&P Biotech ETF by 3.4% in the second quarter. Newbridge Financial Services Group Inc. now owns 12,600 shares of the exchange traded fund’s stock worth $1,168,000 after acquiring an additional 419 shares in the last quarter. Sanctuary Advisors LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter worth $1,247,000. LHM Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 106.5% during the second quarter. LHM Inc. now owns 77,242 shares of the exchange traded fund’s stock valued at $7,161,000 after acquiring an additional 39,828 shares in the last quarter. Finally, Granite Bay Wealth Management LLC raised its position in shares of SPDR S&P Biotech ETF by 4,965.8% in the 2nd quarter. Granite Bay Wealth Management LLC now owns 124,062 shares of the exchange traded fund’s stock worth $11,097,000 after purchasing an additional 121,613 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock traded up $0.87 during mid-day trading on Friday, reaching $97.51. The stock had a trading volume of 5,972,827 shares, compared to its average volume of 9,649,329. The company has a market capitalization of $7.43 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The company has a 50-day moving average price of $98.80 and a two-hundred day moving average price of $94.03.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.